Lymphoma, Large B-Cell, Diffuse

specific

A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases. Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma. Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous dif

51

Centers

32

Active Trials

Cancer Funding

Top Centers for Lymphoma, Large B-Cell, Diffuse(51)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.4
2
NCI Comprehensive
High-Volume Research Center
70.4
3
NCI Clinical
High-Volume Research Center
70.4
4
High-Volume Research Center
70.4
5
NCI Clinical
High-Volume Research Center
70.4
6
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
70.4
7
High-Volume Research Center
70.4
8
NCI Comprehensive
Active Research Program
59.4
9
NCI Comprehensive
Active Research Program
59.4
10
NCI Comprehensive
Active Research Program
59.4
11
NCI Comprehensive
Active Research Program
59.4
12
NCI Comprehensive
Active Research Program
59.4
1359.4
14
NCI Comprehensive
Active Research Program
59.4
15
NCI Comprehensive
Active Research Program
59.4
16
NCI Comprehensive
Active Research Program
59.4
17
Active Research Program
59.4
18
NCI Comprehensive
Active Research Program
59.4
19
NCI Comprehensive
Active Research Program
59.4
20
Active Research Program
59.4
21
Active Research Program
59.4
22
Active Research Program
59.4
23
Active Research Program
59.4
24
Active Research Program
59.4
25
Active Research Program
59.4
26
NCI Comprehensive
40.0
2740.0
2840.0
29
NCI Comprehensive
40.0
30
NCI Comprehensive
40.0
31
NCI Comprehensive
40.0
32
NCI Comprehensive
40.0
33
NCI Comprehensive
40.0
34
NCI Comprehensive
40.0
35
NCI Comprehensive
40.0
36
NCI Comprehensive
40.0
3740.0
38
NCI Comprehensive
40.0
39
NCI Comprehensive
40.0
40
Cedars-Sinai CancerLos Angeles, CA
40.0
4140.0
4240.0
4340.0
4440.0
45
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
40.0
46
NCI Comprehensive
40.0
4740.0
4840.0
4940.0
50
BC CancerVancouver, BC
40.0
5140.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →